Peptide record

TPDB06774

Antibacterial Antifungal Hemolysis Toxicity standard
12 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB06774
Antibacterial Antifungal Hemolysis Toxicity
Anti-infective peptides Toxicity and safety peptides
AntiBP3 Peptipedia Antifungipept CAFPdb dbAMP HemoPI Hemolytic2 PD_Hemolysis
standard
No
A 12-aa standard-residue multi-activity (Antibacterial, Antifungal, Hemolysis, and other sources) peptide sequence curated from AntiBP3, Peptipedia, Antifungipept, and other sources, with an available 3D structural model.
Sequence
RRGWALRLVLAY
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C69H112N22O14
NDCEQHIKMFPST
RL
1473.79
12.11
3
0
8
+3
1.60
0.258
138.33
Mammalian: 1 hour Yeast: 2 min E.coli: 2 min
6990
4.74
1
Residue Composition
number
2
A
3
R
0
N
0
D
0
C
0
E
0
Q
1
G
0
H
0
I
3
L
0
K
0
M
0
F
0
P
0
S
0
T
1
W
1
Y
1
V
Amino Acid Distribution
A: 2 R: 3 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 0 L: 3 K: 0 M: 0 F: 0 P: 0 S: 0 T: 0 W: 1 Y: 1 V: 1
Chemical Descriptors
12 reviewed residue count
C69H112N22O14 sequence-only estimate (linear, free termini)
1473.79 sequence-only estimate (linear, free termini)
12.11 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
1.60 sequence-only estimate (linear, free termini)
0.258 sequence-only estimate (linear, free termini)
Evidence Records 5 records
Evidence 1 Activity

Activity

19% Hemolysis
Toxicity
100 µM
Hemolytic Cytotoxic
19% Hemolysis | 100 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Synthetic molecular evolution of host cell-compatible, antimicrobial peptides effective against drug-resistant, biofilm-forming bacteria. | Proc Natl Acad Sci U S A | 2020
Evidence 2 Activity

Activity

50% Cell death
Toxicity
>200 µM
Cytotoxic
50% Cell death | >200 | µM | target cell: Human fibroblasts WI-38

Target

Human fibroblasts WI-38

Source & Reference

NA
DBAASP
Synthetic molecular evolution of host cell-compatible, antimicrobial peptides effective against drug-resistant, biofilm-forming bacteria. | Proc Natl Acad Sci U S A | 2020
Evidence 3 Activity

Activity

20% Hemolysis
Toxicity
15 µM
Hemolytic Cytotoxic
20% Hemolysis | 15 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity | J Am Chem Soc | 2009
Evidence 4 Activity

Activity

3% Hemolysis
Toxicity
15 µM
Hemolytic Cytotoxic
3% Hemolysis | 15 | µM | target cell: Sheep erythrocytes

Target

Sheep erythrocytes

Source & Reference

NA
DBAASP
Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity | J Am Chem Soc | 2009
Evidence 5 Hemolysis

Source & Reference

HemoPI PD_Hemolysis
PD_Hemolysis